Cargando…

Preoperative Inflammation-Associated Blood Cell Markers in Patients with Non-Metastatic Clear Cell Renal Cell Carcinoma: A Retrospective Study

PURPOSE: This study aimed to investigate the association between preoperative inflammation-associated blood cell markers and the prognosis of patients with non-metastatic clear cell renal cell carcinoma (ccRCC) who underwent nephrectomy. PATIENTS AND METHODS: We retrospectively analyzed data from ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yuling, Kou, Wei, Zhu, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363385/ https://www.ncbi.nlm.nih.gov/pubmed/37489129 http://dx.doi.org/10.2147/IJGM.S417948

Ejemplares similares

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019)

Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
por: Gu, Yufeng, et al.
Publicado: (2023)

Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
por: Vecchio, Sharon J. Del, et al.
Publicado: (2018)

Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma
por: An, Josiah, et al.
Publicado: (2022)

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
por: Evelönn, Emma Andersson, et al.
Publicado: (2019)

Genetic mutations associated with metastatic clear cell renal cell carcinoma
por: Li, Zhongjun, et al.
Publicado: (2016)

Combination drug regimens for metastatic clear cell renal cell carcinoma
por: Khetani, Viraj V, et al.
Publicado: (2020)

Metastatic Clear Cell Renal Cell Carcinoma Presenting as Acute Appendicitis
por: Ushakova, Oxana, et al.
Publicado: (2023)

Real-World Experience With Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma: A Retrospective Analysis
por: Lemke, Emily A., et al.
Publicado: (2019)

Prognostic significance of preoperative and follow-up neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma
por: Kim, Tae Woo, et al.
Publicado: (2019)

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
por: Kontovinis, Loukas F, et al.
Publicado: (2009)

Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma
por: Azuma, Takeshi, et al.
Publicado: (2018)

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
por: Büttner, Florian, et al.
Publicado: (2018)

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
por: Petitprez, Florent, et al.
Publicado: (2021)

Prognostic value and model construction of preoperative inflammatory markers in patients with metastatic renal cell carcinoma
por: Wang, Jichen, et al.
Publicado: (2023)

Annexin II represents metastatic potential in clear-cell renal cell carcinoma
por: Ohno, Y, et al.
Publicado: (2009)

Histologic Variations and Immunohistochemical Features of Metastatic Clear Cell Renal Cell Carcinoma
por: Lee, Cheol, et al.
Publicado: (2013)

Metastatic Clear Cell Renal Cell Carcinoma Presenting with a Gingival Metastasis
por: Ali, Rusha A.E., et al.
Publicado: (2016)

Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma
por: Chiu, I-Jen, et al.
Publicado: (2020)

Metastatic Clear Cell Renal Cell Carcinoma: The Great Pretender and the Great Dilemma
por: Maestroni, Umberto, et al.
Publicado: (2021)

Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma
por: Chatwal, Monica Sheila, et al.
Publicado: (2023)

Metastatic Non-Clear Cell Renal Cell Carcinoma: An Evidence Based Review of Current Treatment Strategies
por: Sankin, Alexander, et al.
Publicado: (2015)

Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease
por: Wagener, Nina, et al.
Publicado: (2017)

Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma
por: Wei, Zongjie, et al.
Publicado: (2022)

Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Determination of Angptl4 mRNA as a Diagnostic Marker of Primary and Metastatic Clear Cell Renal-Cell Carcinoma
por: Verine, Jérôme, et al.
Publicado: (2010)

Correction: Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma
Publicado: (2018)

Metastatic clear cell renal cell carcinoma to the forearm without identifiable primary renal mass
por: Walton, John, et al.
Publicado: (2019)

Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients
por: Chen, Zhen, et al.
Publicado: (2017)

Single‐cell analysis reveals metastatic cell heterogeneity in clear cell renal cell carcinoma
por: Liu, Kun, et al.
Publicado: (2021)

Metastatic renal clear-cell carcinoma to the gallbladder: A radiologist’s perspective
por: Bolus, Christopher C., et al.
Publicado: (2015)

Letter to the editor: Prognostic significance of preoperative and follow-up neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma
por: Joob, Beuy, et al.
Publicado: (2019)

Rare Presentation of Metastatic Lobular Breast Carcinoma Involving Clear Cell Renal Cell Carcinoma
por: Ashman, Dayne, et al.
Publicado: (2020)

Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

The role of immunotherapy in non-clear cell renal cell carcinoma
por: Climent, Carla, et al.
Publicado: (2023)

Identification of gene markers associated with metastasis in clear cell renal cell carcinoma
por: Yang, Hailing, et al.
Publicado: (2017)

Serum Oxidative and Nitrosative Stress Markers in Clear Cell Renal Cell Carcinoma
por: Galiniak, Sabina, et al.
Publicado: (2023)

Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Chen, Shao-An, et al.
Publicado: (2023)

A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma
por: Sekar, Rishi R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_laa1c0h0eu6upb6uv9u22a1tp0